Varian Medical (VAR) Posts Q4 EPS of $0.78, Beats by 4c; Guides
More News related to VAR
- University College Hospital in London Introduces Treatments Delivering Faster Form of Radiotherapy
- Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
- Varian Medical (VAR) Discloses New 5M Share Buyback Plan
- Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
- Researchers from UC Irvine Medical Center Find Clinical Advantages to Using RapidArc(R) Radiotherapy for the Stereotactic Treatment of Tumors
More News related to Earnings
- BMO Capital Downgrades Terra Industries (TRA) to Market Perform
- FTN Equity Downgrades Momenta Pharmaceuticals (MNTA) to Neutral
- Sterne Agee Downgrades Shoe Apparel Stores FINL & FL
- Morgan Stanley Downgrades Western Gas Partners (WES) to Equalweight
- J.P. Morgan Downgrades Hibbett Sports (HIBB) to Neutral
Varian Medical Systems, Inc. (NYSE: VAR) reports Q4 EPS of $0.78, 4 cents better than the analyst estimate of $0.74. Revenue for the quarter was $642 million, which compares to the estimate of $593.17 million.
Sees Q1 EPS $0.52 - $0.56, versus $0.60, and sees revs up 3 - 4 %.
Also sees FY10 EPS $2.65 - $2.75, versus $2.71.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.98Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
